RecruitingNot ApplicableNCT05927818

Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer

Efficacy of Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer


Sponsor

Istanbul University

Enrollment

100 participants

Start Date

Apr 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing it to the results obtained from systematic lymphadenectomy, each performed in participants with a suspicious adnexal mass for early-stage ovarian cancer.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study investigates whether sentinel lymph node biopsy (a technique to check nearby lymph nodes for cancer spread using a special dye) works accurately in early-stage ovarian cancer, potentially reducing the need for more extensive lymph node removal. **You may be eligible if...** - You have a suspicious ovarian mass that looks like it could be early-stage ovarian cancer - You are healthy enough to have the sentinel lymph node procedure and full lymph node surgery **You may NOT be eligible if...** - Your ovarian mass is unlikely to be early-stage ovarian cancer - You have medical or surgical reasons that prevent you from having full staging surgery - You have cancer that has spread from another organ to the ovary - You have had ovarian cancer before - Your cancer is found to be advanced (stage III or IV) during the operation - You have already received chemotherapy before surgery (neoadjuvant treatment) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTSentinel lymph node biopsy (using sterile charcoal stain) in early ovarian cancer

Described in previous sections


Locations(1)

Istanbul University

Istanbul, Turkey, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05927818


Related Trials